{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:04:26Z","timestamp":1793160266631,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["K08CA241365"],"award-info":[{"award-number":["K08CA241365"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006098","name":"Radiological Society of North America","doi-asserted-by":"publisher","award":["Research Scholar Grant"],"award-info":[{"award-number":["Research Scholar Grant"]}],"id":[{"id":"10.13039\/100006098","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Electronic Space Systems Corporation (ESSCO)-MGH Breast Cancer Research Fund","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s00330-020-07021-2","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T09:04:05Z","timestamp":1593162245000},"page":"6089-6098","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Ductal carcinoma in situ on digital mammography versus digital breast tomosynthesis: rates and predictors of pathologic upgrade"],"prefix":"10.1007","volume":"30","author":[{"given":"Geunwon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Mikhael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawakalitu O.","family":"Oseni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7728-7690","authenticated-orcid":false,"given":"Manisha","family":"Bahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,26]]},"reference":[{"key":"7021_CR1","unstructured":"American Cancer Society (2019) How common is breast cancer? Available via https:\/\/www.cancer.org\/cancer\/breast-cancer\/about\/how-common-is-breast-cancer.html. Accessed 27 Dec 2019"},{"key":"7021_CR2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/jbi\/wbz039","volume":"1","author":"M Shehata","year":"2019","unstructured":"Shehata M, Grimm L, Ballantyne N et al (2019) Ductal carcinoma in situ: current concepts in biology, imaging, and treatment. J Breast Imaging 1:166\u2013176","journal-title":"J Breast Imaging"},{"key":"7021_CR3","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1148\/radiology.219.3.r01jn34793","volume":"219","author":"RF Brem","year":"2001","unstructured":"Brem RF, Schoonjans JM, Goodman SN, Nolten A, Askin FB, Gatewood OM (2001) Nonpalpable breast cancer: percutaneous diagnosis with 11- and 8-gauge stereotactic vacuum-assisted biopsy devices. Radiology 219:793\u2013796","journal-title":"Radiology"},{"key":"7021_CR4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1148\/radiology.218.2.r01fe35497","volume":"218","author":"RJ Jackman","year":"2001","unstructured":"Jackman RJ, Burbank F, Parker SH et al (2001) Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. Radiology 218:497\u2013502","journal-title":"Radiology"},{"key":"7021_CR5","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0959-8049(00)00397-X","volume":"37","author":"Y Wahedna","year":"2001","unstructured":"Wahedna Y, Evans AJ, Pinder SE, Ellis IO, Blamey RW, Geraghty JG (2001) Mammographic size of ductal carcinoma in situ does not predict the presence of an invasive focus. Eur J Cancer 37:459\u2013462","journal-title":"Eur J Cancer"},{"key":"7021_CR6","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10549-006-9167-2","volume":"98","author":"A Goyal","year":"2006","unstructured":"Goyal A, Douglas-Jones A, Monypenny I, Sweetland H, Stevens G, Mansel RE (2006) Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases. Breast Cancer Res Treat 98:311\u2013314","journal-title":"Breast Cancer Res Treat"},{"key":"7021_CR7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1148\/radiol.11102368","volume":"260","author":"ME Brennan","year":"2011","unstructured":"Brennan ME, Turner RM, Ciatto S et al (2011) Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer. Radiology 260:119\u2013128","journal-title":"Radiology"},{"key":"7021_CR8","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1245\/s10434-010-1438-9","volume":"18","author":"N Houssami","year":"2011","unstructured":"Houssami N, Ambrogetti D, Marinovich ML et al (2011) Accuracy of a preoperative model for predicting invasive breast cancer in women with ductal carcinoma-in-situ on vacuum-assisted core needle biopsy. Ann Surg Oncol 18:1364\u20131371","journal-title":"Ann Surg Oncol"},{"key":"7021_CR9","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.breast.2012.06.012","volume":"21","author":"J Kim","year":"2012","unstructured":"Kim J, Han W, Lee JW et al (2012) Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision. Breast 21:641\u2013645","journal-title":"Breast"},{"key":"7021_CR10","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.breast.2012.11.002","volume":"22","author":"S Schulz","year":"2013","unstructured":"Schulz S, Sinn P, Golatta M et al (2013) Prediction of underestimated invasiveness in patients with ductal carcinoma in situ of the breast on percutaneous biopsy as rationale for recommending concurrent sentinel lymph node biopsy. Breast 22:537\u2013542","journal-title":"Breast"},{"key":"7021_CR11","doi-asserted-by":"publisher","unstructured":"Lamb LR, Lehman CD, Oseni TO, Bahl M (2019) Ductal carcinoma in situ (DCIS) at breast MRI: predictors of upgrade to invasive carcinoma. Acad Radiol. https:\/\/doi.org\/10.1016\/j.acra.2019.09.025","DOI":"10.1016\/j.acra.2019.09.025"},{"key":"7021_CR12","doi-asserted-by":"publisher","unstructured":"Lamb LR, Kim G, Oseni TO, Bahl M (2020) Noncalcified ductal carcinoma in situ (DCIS): rate and predictors of upgrade to invasive carcinoma. Acad Radiol. https:\/\/doi.org\/10.1016\/j.acra.2020.02.011","DOI":"10.1016\/j.acra.2020.02.011"},{"key":"7021_CR13","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.ejca.2015.05.008","volume":"51","author":"LE Elshof","year":"2015","unstructured":"Elshof LE, Tryfonidis K, Slaets L et al (2015) Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - the LORD study. Eur J Cancer 51:1497\u20131510","journal-title":"Eur J Cancer"},{"key":"7021_CR14","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1016\/j.ejca.2015.07.017","volume":"51","author":"A Francis","year":"2015","unstructured":"Francis A, Thomas J, Fallowfield L et al (2015) Addressing overtreatment of screen detected DCIS; the LORIS trial. Eur J Cancer 51:2296\u20132303","journal-title":"Eur J Cancer"},{"key":"7021_CR15","doi-asserted-by":"publisher","first-page":"e026797","DOI":"10.1136\/bmjopen-2018-026797","volume":"9","author":"ES Hwang","year":"2019","unstructured":"Hwang ES, Hyslop T, Lynch T et al (2019) The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS). BMJ Open 9:e026797","journal-title":"BMJ Open"},{"key":"7021_CR16","unstructured":"NIPH Clinical Trials Search (2017) Single-arm confirmatory trial of endocrine therapy alone for estrogen receptor-positive, low-risk ductal carcinoma in situ of the breast (JCOG1505, LORETTA trial). Available via https:\/\/rctportal.niph.go.jp\/en\/detail?trial_id=UMIN000028298. Accessed 27 Dec 2019"},{"key":"7021_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11864-012-0217-1","volume":"14","author":"N Bijker","year":"2013","unstructured":"Bijker N, Donker M, Wesseling J, den Heeten GJ, Rutgers EJ (2013) Is DCIS breast cancer, and how do I treat it? Curr Treat Options Oncol 14:75\u201387","journal-title":"Curr Treat Options Oncol"},{"key":"7021_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1148\/radiol.12121373","volume":"267","author":"P Skaane","year":"2013","unstructured":"Skaane P, Bandos AI, Gullien R et al (2013) Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program. Radiology 267:47\u201356","journal-title":"Radiology"},{"key":"7021_CR19","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1001\/jama.2014.6095","volume":"311","author":"SM Friedewald","year":"2014","unstructured":"Friedewald SM, Rafferty EA, Rose SL et al (2014) Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA 311:2499\u20132507","journal-title":"JAMA"},{"key":"7021_CR20","doi-asserted-by":"publisher","first-page":"687","DOI":"10.2214\/AJR.14.12642","volume":"203","author":"JS Greenberg","year":"2014","unstructured":"Greenberg JS, Javitt MC, Katzen J, Michael S, Holland AE (2014) Clinical performance metrics of 3D digital breast tomosynthesis compared with 2D digital mammography for breast cancer screening in community practice. AJR Am J Roentgenol 203:687\u2013693","journal-title":"AJR Am J Roentgenol"},{"key":"7021_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1148\/radiology.172.1.2544922","volume":"172","author":"PC Stomper","year":"1989","unstructured":"Stomper PC, Connolly JL, Meyer JE, Harris JR (1989) Clinically occult ductal carcinoma in situ detected with mammography: analysis of 100 cases with radiologic-pathologic correlation. Radiology 172:235\u2013241","journal-title":"Radiology"},{"key":"7021_CR22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1148\/radiol.2016151999","volume":"281","author":"M Raghu","year":"2016","unstructured":"Raghu M, Durand MA, Andrejeva L et al (2016) Tomosynthesis in the diagnostic setting: changing rates of BI-RADS final assessment over time. Radiology 281:54\u201361","journal-title":"Radiology"},{"key":"7021_CR23","doi-asserted-by":"crossref","unstructured":"Bahl M, Mercaldo S, Vijapura CA, McCarthy AM, Lehman CD (2019) Comparison of performance metrics with digital 2D versus tomosynthesis mammography in the diagnostic setting. Eur Radiol 29:477\u2013484","DOI":"10.1007\/s00330-018-5596-7"},{"key":"7021_CR24","doi-asserted-by":"crossref","unstructured":"Doria MT, Maesaka JY, Soares de Azevedo Neto R, de Barros N, Baracat EC, Filassi JR (2018) Development of a model to predict invasiveness in ductal carcinoma in situ diagnosed by percutaneous biopsy-original study and critical evaluation of the literature. Clin Breast Cancer 18:e805\u2013e812","DOI":"10.1016\/j.clbc.2018.04.011"},{"key":"7021_CR25","doi-asserted-by":"crossref","unstructured":"Marques LC, Marta GN, de Andrade JZ, Andrade D, de Barros ACSD, Andrade FEM (2019) Is it possible to predict underestimation in ductal carcinoma in situ of the breast? Yes, using a simple score! Eur J Surg Oncol 45:1152\u20131155","DOI":"10.1016\/j.ejso.2019.01.015"},{"key":"7021_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1148\/radiol.2017171148","volume":"287","author":"M Bahl","year":"2018","unstructured":"Bahl M, Gaffney S, McCarthy AM, Lowry KP, Dang PA, Lehman CD (2018) Breast cancer characteristics associated with 2D digital mammography versus digital breast tomosynthesis for screening-detected and interval cancers. Radiology 287:49\u201357","journal-title":"Radiology"},{"key":"7021_CR27","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.jamcollsurg.2017.12.049","volume":"226","author":"LR Lamb","year":"2018","unstructured":"Lamb LR, Bahl M, Hughes KS, Lehman CD (2018) Pathologic upgrade rates of high-risk breast lesions on digital two-dimensional vs tomosynthesis mammography. J Am Coll Surg 226:858\u2013867","journal-title":"J Am Coll Surg"},{"key":"7021_CR28","unstructured":"National Cancer Institute (2019) TMIST (Tomosynthesis Mammographic Imaging Screening Trial). Available via https:\/\/www.cancer.gov\/about-cancer\/treatment\/clinical-trials\/nci-supported\/tmist. Accessed 27 Dec 2019"},{"key":"7021_CR29","doi-asserted-by":"publisher","first-page":"941","DOI":"10.2214\/ajr.180.4.1800941","volume":"180","author":"MS Soo","year":"2003","unstructured":"Soo MS, Baker JA, Rosen EL (2003) Sonographic detection and sonographically guided biopsy of breast microcalcifications. AJR Am J Roentgenol 180:941\u2013948","journal-title":"AJR Am J Roentgenol"},{"key":"7021_CR30","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1148\/radiol.2018181788","volume":"290","author":"M Bahl","year":"2019","unstructured":"Bahl M, Maunglay M, D'Alessandro HA, Lehman CD (2019) Comparison of upright digital breast tomosynthesis-guided versus prone stereotactic vacuum-assisted breast biopsy. Radiology 290:298\u2013304","journal-title":"Radiology"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-020-07021-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-020-07021-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-020-07021-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T23:25:29Z","timestamp":1624663529000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-020-07021-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["7021"],"URL":"https:\/\/doi.org\/10.1007\/s00330-020-07021-2","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,26]]},"assertion":[{"value":"31 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Manisha Bahl, MD, MPH.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the institutional review board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional review board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"We have submitted or previously published manuscripts in which there is overlap of patients with this study:","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"value":"\u2022 retrospective\u2022 observational\u2022 performed at one institution","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}